Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) - AMR Interventions 2024


Announcement "open"
I'm interested
Organization:
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
Scope:
International
Start:
Internal deadline:
Official deadline:
Amount:
Discretionary
Description:

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is an international collaborative platform engaging 29 nations and the European Commission to curb antimicrobial resistance (AMR).

JPIAMR has launched the 17th transnational call for research projects under the umbrella of JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION.

Interventions Moving Forward To Promote Action To Counteract the Emergence and Spread of Bacterial and Fungal Resistance and To Improve Treatments will involve 21 funders from 19 countries. The total estimated call budget is over €17.7 million.

The call is designed to address the growing global threat of increased spread of antimicrobial (antibacterial and antifungal) resistance by funding international collaborative research projects aiming to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections.

Proposals should address one of the two topics of the call:

Topic 1: Design novel or improved interventions to prevent, mitigate and/or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance

The novel interventions for Topic 1 may include, but are not limited to: prevention strategies; treatments based on new or existing compounds or technologies; improved or novel diagnostics or surveillance.

Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

The following sub-topics are out of the scope of the call:

  • Antivirals and antiparasitics.
  • Proposals solely aiming to treat plant or animal infections without link to human health.
  • Proposals solely aiming to extend existing or implement new surveillance systems.

Pre-proposals should be submitted by the 14 March 2024 (14:00) deadline.

Requirements

Applicant consortia must include a minimum of three eligible project partners asking for funding from three different eligible countries (including at least two amongst EU Member States or Associated Countries).

The consortium can include a maximum of six project partners. The maximum number of project partners can be increased to seven if the consortium includes:

  • At least one project partner from an under-represented country; or
  • At least one project partner where the Principal Investigator (PI) meets the definition of an Early Career Researcher; or
  • A company.

The consortium can include a maximum of two partners from the same country per proposal. Project partners not eligible for funding may be involved in projects if they provide their own funding.

Applicants must adhere to the specific regulations of their national funding partner organisation (FPO). Each project partner is therefore strongly advised to carefully check the national eligibility rules defined by their own funding organisation.

Request

In case of interest, please click on "m'interessa" and we will contact you.